The data shows that inhibiting TIE2 with rebastinib could prevent new abnormalities from forming in the brain with fewer side effects.
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a cell surface receptor ...
Abbreviations: 4EBP1, 4E binding protein 1; BCL-2, B-cell lymphoma 2; EEF2K, eukaryotic elongation factor-2 kinase; EIF4B, eukaryotic translation initiation factor 4B; ERK, extracellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results